Summary P-glycoprotein (Pgp) and pi-class glutathione S-transferase (GSTPI-1) are thought to be correlated with multiple drug resistance. In immunohistochemical staining, non-seminomatous germ cell tumours, which are more refractory than seminomas to anti-cancer chemotherapy, frequently expressed Pgp and GSTP1-1. Western blot analysis demonstrated lower amount of GSTPl-l in seminoma than in teratoma. These results suggest that Pgp and GSTPI-I might contribute to drug resistance in testis cancers
Multiple drug resistance (MDR) is a major problem in the treatment of cancer and is reported to be attributed to P-glycoprotein (Pgp) and glutathione metabolism (Kramer et al., 1988; Mickisch et al., 1990) . It is well known that malignant tumours and cell lines which show marked resistance to anti-cancer drugs frequently express Pgp, which is a 170-kDa cell membrane glycoprotein thought to act as an energydependent drug efflux pump (Gerlach et al., 1986) . Pharmacologically, cells overexpressing Pgp exhibit reduced intracellular accumulation of a number of drugs (Gerlach et al., 1986; Dalton et al., 1989; Miller et al., 1991; Kanamaru et al., 1989) .
In the glutathione metabolism which is of special importance for cellular protection against free radicals and exogenous compounds including anti-cancer drugs, GST is thought to play the most important role in MDR (Kramer et al., 1988) . Human cytosolic GSTs are classified into four groups, alpha, mu, pi and theta (Mannervik et al., 1992) . Among these isoenzymes, predominant expression and increased activity of pi-class GST (GSTPI-1) is found in many human tumour tissues and cell lines which show resistance to anti-cancer drugs (Hara et al., 1990; Kodate et al., 1986; Shiratori et al., 1987; Ail-Osman et al., 1990; Nakagawa et al., 1988) . GSTPI-I has also been considered as a potential marker of neoplastic lesions in several organs (Kodate et al., 1986; Niitsu et al., 1990; Shiratori et al., 1987) .
Testis cancers are classified clinically into two groups, seminomas and non-seminomatous germ cell tumours (NSGCTs), which differ markedly in their sensitivity to chemotherapeutic agents (Ellis et al., 1987 (UICC, 1989) .
Reagents
In this study we used a monoclonal antibody, JSB-1 (IgGj)
against Pgp (Sanbio Co., Am Uden, Holland), a polyclonal antibody, mdr (ab-1) against Pgp (Oncogene Science Inc., Manhasset, NY, USA), and two polyclonal antibodies against GSTPl-I raised against human placenta (Bioprep Co., Dublin, Ireland, Cosmo Bio Co., Tokyo, Japan).
Immunoperoxidase staining Immunoperoxidase staining was performed using the streptavidin-biotin bridge technique as previously reported (Tomita et al., 1990) . Briefly, serial sections prepared in a cryostat were air-dried for 30 min and fixed in cold acetone for 10 min. After rehydration with PBS, the sections were incubated in PBS containing 20% normal sheep serum or normal donkey serum (Antibodies Inc., Davis, CA, USA) for 30 min and endogenous biotin was blocked using an Endogenous Biotin Blocking Kit (Vector Laboratories, Burlingame, CA, USA). The sections were then incubated with primary antibody for 60 min followed by incubation with biotinylated anti-mouse or anti-rabbit immunoglobulin (Amersham International, Amersham, Bucks, UK) diluted 1:100, containing 20% human type AB serum (Biological Speciality Co., Landscale, PA, USA). Subsequently, they were incubated with streptavidin peroxidase (Amersham) diluted 1: 100 for 45 min. Each step was followed by washing in PBS with three changes of the buffer. The sections were then immersed in 0.05% diaminobenzidine (Sigma Chemical Co., St Louis, MO, USA) and 0.01% H202 in 0.05 M Tris HCI buffer for 3-5 min to visualise the reaction products. After washing in tap-water, specimens were counterstained with Mayer's haematoxylin and mounted with Eukitt (O. Kuldler, Freiburg, FRG) after dehydration in a graded ethanol series and xylene. As a negative control, the JSB-1 (murine) monoclonal antibody was replaced by mouse monoclonal antibody of the same subclass (IgG,), anti-Leul2 (Becton Dickinson, Mountain View, CA, USA), and the (rabbit) polyclonal antibodies were replaced by rabbit polyclonal antibody, anti-IL-6 (Genzyme Co., Boston, MA, USA). As a positive control for Pgp, proximal tubules in a kidney from a patient who underwent nephrectomy for renal trauma were examined, and for GSTPI-1, the staining pattern of trophoblast in term placenta obtained from normal delivery was checked.
Western blot analysis Tissue samples were homogenised in 2-3 volumes of 50 mM sodium phosphate buffer (pH 6.5 at 4C), sonicated for 30 s, and centrifuged at 12,000 g for 40 min. Western blotting of the supernatant was performed as described by Towbin et al. (Towbin et al., 1979 (Tables II and III) . Among NSGCTs, all of seven teratomas were stained with all antibodies against Pgp and GSTPI-1, glandular epithelial cells being most strongly stained at their apical portion (Figures 1 and 2) . The distribution of the positively stained cases was similar in both Pgp and GSTPI-1 (Table IV) . Two of five embryonal cell carcinomas showed weak staining with JSB-1 mdr(ab-1). GSTP1-1 was detected in one of five embryonal cell carcinomas. The elements of yolk sac tumour did not react with all antibodies used. Expression of Pgp or GSTP1-1 and clinical stage were not correlated (Table V) . Figure 3 demonstrated immunoprecipitation of GSTPI-I of Mr 23,000 both in teratoma (lane 1) and seminoma (lanes 2, 3). Seminoma (lanes 2, 3) showed lower intensity band of GSTPI-l than teratoma (lane 1) on blotted membrane, indicating lower amount of GSTP1-I in seminoma than teratoma.
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Discussion
A decrease of intracellular drug accumulation by efflux through Pgp results in MDR of tumour cells (Gerlach et al., 1986; Dalton et al., 1989; Miller et al., 1991; Kanamaru et al., 1989) . It has been reported that resistance to doxorubicin and vinblastine is correlated to the expression of Pgp (Mickisch et al., 1990; Miller et al., 1991) . Recent studies have also shown that MDR can be induced in drug-sensitive cells by transfection of genes encoding Pgp (Ueda et al., 1987) . However, in a doxorubicin-resistant breast cancer cell line with Pgp, drug resistance was not reversed completely even when intracellular drug accumulation was increased, suggesting that another mechanism operates in MDR apart from Pgp (Kramer et al., 1988) . Overexpression and increased activity of GSTPI-1 are also found in tumour cells which show resistance to anti-cancer drugs (Ail-Osman et al., 1990; Shea et al., 1988). Therefore, GSTPI-I is thought to be at least partly responsible for MDR. In fact, correlation between GSTP1-I expression and resistance to platinum compounds, alkylating agents, nitrosourea and doxorubicin has been reported (Ail-Osman et al., 1990; Nakagawa et al., 1988; Niitsu et al., 1990 Testis cancer is one of the tumours most sensitive to chemotherapy, and the overall cure rate of disseminated testis cancer to chemotherapy is as high as 70-80% (Williams et al., 1987) . However, NSGCTs are rather resistant to chemotherapy, and choriocarcinoma and teratoma with embryonal cell carcinoma (teratocarcinoma) have been reported to have a poor prognosis (Ellis et al., 1987; Williams et al., 1987; Wettlaufer et al., 1984) . Salvage surgery for the residual mass after chemotherapy frequently reveals a residue of mature teratoma (Ellis et al., 1987) , suggesting resistance of teratoma to chemotherapeutic agents. In this study, Pgp and GSTPl-l were detected more frequently in NSGCTs,. especially in teratomas, than in seminomas, and a significant difference was noticed (P<0.05). This suggests that the expression of Pgp or GSTPl-l could be an indicator of sensitivity to anti-cancer drugs. A previous study showed GSTPl-l expression in all histological types of testis cancer immunohistochemically (Klys et al., 1992) . However, Western-blot analysis performed in the present study demonstrated lower intensity of GSTP1-1 in seminoma than in teratoma on the blotted membrane, suggesting lower amounts of GSTP1-1 in seminoma than in teratoma ( Figure   3 ).
Each element of teratoma, including epithelial cells, smooth muscle cells, and chondrocytes, showed a similar staining pattern to that of the corresponding normal tissue reported previously (Cordon-Cardo et al., 1990; Kantor et al., 1991) . Thus, the expression of Pgp or GSTPI-I in teratoma might be related to the degree of differentiation, which has also been reported for renal cell carcinoma (Kanamaru et al., 1989) . Differentiated tissues often show less susceptibility to anti-cancer drugs, and that is thought to be attributed to low proliferative activity. A recent study demonstrated that proliferative activity detected by thymidine labelling index was inversely correlated with expression of Pgp or GSTPI-1 (Volm et al., 1992) . Therefore, the resistance mechanism mediated by Pgp or GSTPI-1, which is associated with low proliferative activity, might contribute at least partly to refractoriness to chemotherapy in differentiated tumours.
In this study, expression of Pgp correlated positively with that of GSTPI-I (P<0.01), as in the report of lung cancer (Volm et al., 1992) . This correlation is unlikely to derive from the character of the original tissue because previous reports showed weak or no expression of Pgp or GSTP1-I in normal germ cells (Cordon-Cardo et al., 1990; Kantor et al., 1991) . At present, there are no data on the existence of co-regulation mechanisms for Pgp and GSTP1-1.
Finally, our results suggest that Pgp or GSTP1-1 expression, predominantly in teratoma, might be correlated with the difference in sensitivity to chemotherapy of different histological types of testis cancer. However, correlation between the expression of Pgp or GSTP1-1 and clinical factors including prognosis in more cases of advanced stage or refractory history remains to be examined.
